CAMBRIDGE, Mass., April 27, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its partner, Pfizer, has presented preclinical data on PF-08052666 (HBM9033; SGN-MesoC2), a first-in-class...
Read More Details
Finally We wish PressBee provided you with enough information of ( Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025 )
Also on site :
- At Least 11 Dead After Driver Plowed Into Crowd at a Filipino Festival in Vancouver
- What to know about the trial of an ex-Michigan cop charged in the killing of a Black motorist
- U.S. Military Says Its Air Campaign Has Hit More Than 800 Targets in Yemen